Icecure Medical Ltd (NASDAQ: ICCM) on Tuesday, plunged -6.02% from the previous trading day, before settling in for the closing price of $0.65. Within the past 52 weeks, ICCM’s price has moved between $0.59 and $1.63.
Annual sales at Healthcare sector company grew by 2.44% over the past five years. The company achieved an average annual earnings per share of 26.96%. With a float of $40.31 million, this company’s outstanding shares have now reached $68.96 million.
Icecure Medical Ltd (ICCM) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Icecure Medical Ltd is 41.31%, while institutional ownership is 0.43%.
Icecure Medical Ltd (ICCM) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.07) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.05% during the next five years compared to 2.44% growth over the previous five years of trading.
Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators
Icecure Medical Ltd (ICCM) is currently performing well based on its current performance indicators. A quick ratio of 1.90 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Icecure Medical Ltd (ICCM)
Icecure Medical Ltd (NASDAQ: ICCM) saw its 5-day average volume 0.4 million, a negative change from its year-to-date volume of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 28.35%.
During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 2.47%, which indicates a significant increase from 0.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0329 in the past 14 days, which was lower than the 0.0527 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7062, while its 200-day Moving Average is $0.9566. Nevertheless, the first resistance level for the watch stands at $0.6334 in the near term. At $0.6567, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6685. If the price goes on to break the first support level at $0.5983, it is likely to go to the next support level at $0.5865. The third support level lies at $0.5632 if the price breaches the second support level.
Icecure Medical Ltd (NASDAQ: ICCM) Key Stats
Market capitalization of the company is 41.90 million based on 68,699K outstanding shares. Right now, sales total 3,290 K and income totals -15,320 K. The company made 850 K in profit during its latest quarter, and -3,860 K in sales during its previous quarter.
